Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Pinto

Orthopaedic Surgery Lacombe, LA Medical Doctor

NPI 1760447379 CMS profile 215219

64301 Highway 434, Lacombe, LA 70445

Open in the dashboard

General payments

$11,367

154 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeffrey Pinto of Lacombe, LA is reported in the CMS Open Payments database as having received $11,367 across 154 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,001 12
2024 General $3,632 43
2023 General $1,747 13
2022 General $491 9
2021 General $899 20
2020 General $1,432 27
2019 General $1,165 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Pinto
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Jeffrey Pinto were reported at $2,001. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Jeffrey Pinto Orthopaedic Surgery median Middle half National median
2019 $1,165 $644 $140–$2,844 $163
2020 $1,432 $312 $75–$1,860 $114
2021 $899 $520 $117–$2,495 $132
2022 $491 $598 $128–$2,731 $149
2023 $1,747 $461 $128–$2,264 $160
2024 $3,632 $497 $134–$2,475 $164
2025 $2,001 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $2,814 16 payments
  2. Alphatec Spine, Inc $2,301 13 payments
  3. Alon Medical Technology $2,024 16 payments
  4. Arthrex, Inc. $1,726 22 payments
  5. Zimmer Biomet Holdings, Inc. $700 8 payments
  6. Grifols USA, LLC $230 13 payments
  7. Providence Medical Technology, Inc. $216 5 payments
  8. Boston Scientific Corporation $147 4 payments
  9. Medtronic, Inc. $103 3 payments
  10. Spinal Simplicity, LLC $102 1 payment
  11. Other $1,003 53 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $6,466 28 payments
  2. Food and Beverage $4,646 119 payments
  3. Education $187 3 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $68 4 payments
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $1,440 8 payments
  2. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $1,320 5 payments
  3. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $871 5 payments
  4. Mobi-C $514 5 payments
  5. Gamunex-C $230 13 payments
  6. Biomet SpinalPak $187 3 payments
  7. SPECTRA WAVEWRITER $133 3 payments
  8. HA MINUTEMAN G3-R $102 1 payment
  9. Vital $86 1 payment
  10. MAZOR X SYSTEM $80 2 payments
  11. Other $1,161 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

197

Median for Orthopedic Surgery: 203

Drug cost

$2,059

Median for Orthopedic Surgery: $1,433

Branded share of claims

48.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 82 $1,093
Gabapentin Generic 21 $270
Cyclobenzaprine Hcl Generic 26 $247
Cephalexin Generic 13 $160
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 13 $151
Methylprednisolone Generic 11 $74
Tramadol Hcl Generic 16 $45
Diazepam Generic 15 $19

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$69,779

Medicare's payments for the services billed

Medicare patients

85

Average age 72

Services billed

432

50 women, 35 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 44%
Diabetes 29%
Depression 29%
Chronic kidney disease 25%
COPD 24%
Osteoporosis 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record